Publication | Closed Access
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial
574
Citations
22
References
2021
Year
Lymphoid NeoplasiaAxicabtagene CiloleucelMedicinePathologyPharmacotherapyCancer TreatmentPhase 2ImmunotherapyOncologyRadiation OncologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1